AIDX - 20/20 Biolabs, Inc.

1.88
0   0%

Share volume: 43,669
Last Updated: 04-01-2026
Business Services/Services – Research, Development, Testing Labs: -0.03%

PREVIOUS CLOSE
CHG
CHG%
$1.88
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
0%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 0%
Performance
5 Days
5.62%
1 Month
-44.54%
3 Months
-92.12%
6 Months
-92.12%
1 Year
-92.12%
2 Year
-92.12%
Key data
Stock price
$1.88
P/E Ratio 
N/A
DAY RANGE
$1.81 - $1.92
EPS 
N/A
52 WEEK RANGE
$1.51 - $50.00
52 WEEK CHANGE
-$92.12
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
0.000
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$510,443
AVERAGE 30 VOLUME 
$360,382
Company detail
CEO: Jonathan Cohen
Region: US
Website: 2020biolabs.com
Employees: 14
IPO year: 2026
Issue type:
Market: XNAS
Industry: Business Services/Services – Research, Development, Testing Labs
Sector: Services

We develop and commercialize AI-powered, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases. Our principal executive offices are located in Gaithersburg, MD.

Recent news